Zentalis Pharmaceuticals, Inc. ($ZNTL)
Filing Information
| Accession Number | 0001838041-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 11, 2026 |
| Document Date | Feb 6, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
3,297
Total Value
$7,998.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 6, 2026 | Sale | 2,962 | $2.43 | $7,196.77 | 33,667 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 9, 2026 | Sale | 335 | $2.39 | $801.62 | 33,332 | Direct | โ | View Details |